These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3817933)

  • 21. Immune-regulation of the apolipoprotein A-I/C-III/A-IV gene cluster in experimental inflammation.
    Navarro MA; Carpintero R; Acín S; Arbonés-Mainar JM; Calleja L; Carnicer R; Surra JC; Guzmán-García MA; González-Ramón N; Iturralde M; Lampreave F; Piñeiro A; Osada J
    Cytokine; 2005 Jul; 31(1):52-63. PubMed ID: 15878672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased susceptibility of LDL to in vitro oxidation in patients with insulin-dependent and non-insulin-dependent diabetes mellitus.
    Cominacini L; Garbin U; Pastorino AM; Fratta Pasini A; Campagnola M; De Santis A; Davoli A; Lo Cascio V
    Diabetes Res; 1994; 26(4):173-84. PubMed ID: 7648791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Apolipoprotein C-I, C-II, C-III].
    Fukushima N; Yamamoto K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():110-3. PubMed ID: 15658276
    [No Abstract]   [Full Text] [Related]  

  • 24. Modifications in apoprotein C composition of very low density lipoproteins in type IV hyperlipoproteinemic subjects after dietetic triglyceridemia reduction.
    Lambert D; Max JP; Mejean L; Pointel JP; Drouin P; Debry G
    Ann Biol Clin (Paris); 1983; 41(4):251-4. PubMed ID: 6638619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Application of the immunoenzyme technic in double determination of antibodies for the study of hyperlipoproteinemia].
    Kandoussi A; Cachera C; Reade R; Tacquet A; Fruchart JC
    Ann Biol Clin (Paris); 1990; 48(6):365-8. PubMed ID: 2221495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Why there is an IRS.
    O'Brien RM; Granner DK
    J Clin Invest; 1995 Dec; 96(6):2546. PubMed ID: 8675617
    [No Abstract]   [Full Text] [Related]  

  • 27. Catabolism of very-low-density lipoproteins in subjects with broad beta disease: comparison with endogenous hypertriglyceridemia.
    Kushwaha RS; Chait A; Hazzard WR
    J Lab Clin Med; 1982 Jan; 99(1):15-24. PubMed ID: 6948063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in paraoxonase and apolipoprotein A-I, B, C-III and E in subjects with combined familiar hyperlipoproteinemia treated with ciprofibrate.
    Turay J; Grniaková V; Valka J
    Drugs Exp Clin Res; 2000; 26(3):83-8. PubMed ID: 10941600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of acipimox on diabetes mellitus-associated hyperlipoproteinemia].
    Paragh G; Balogh Z; Boda J; Mohácsi A; Juhász A; Leövey A
    Orv Hetil; 1993 Jan; 134(3):121-4. PubMed ID: 8421622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetic lipemia with fatty splenomegaly culminating in unnecessary splenectomy.
    Small JM; Moatamed F; Deiss A; Wilson DE
    West J Med; 1987 Aug; 147(2):196-8. PubMed ID: 3660780
    [No Abstract]   [Full Text] [Related]  

  • 31. [Apolipoprotein AI-CIII, B, and CII gene polymorphisms in patients with non-insulin dependent diabetes mellitus. Association with hyperlipemia].
    Gutiérrez C; Vendrell J; Broch M; Pastor R; Llor C; Simón I; Richart C
    Med Clin (Barc); 1996 Nov; 107(15):561-5. PubMed ID: 9064379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study on apoE gene polymorphism and subclasses of serum high density lipoprotein in type IV hyperlipidemia].
    Tian Y; Long SY; Xu YH; Fu MD; Zhang XM; Liu BW
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Feb; 22(1):96-8. PubMed ID: 15696494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein assays: methodological considerations and studies in non-insulin-dependent diabetes treated by diet, glibenclamide and insulin.
    Billingham MS; Milles JJ; Green A; Bailey CJ; Hall RA
    Scand J Clin Lab Invest; 1989 May; 49(3):239-47. PubMed ID: 2500699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apo C subclasses from non-insulin-dependent diabetic patients--a quantitative comparison with control subjects.
    Venkatesan S; Imrie H; Read S; Halliday D
    Biochem Soc Trans; 1995 May; 23(2):278S. PubMed ID: 7672305
    [No Abstract]   [Full Text] [Related]  

  • 35. Hypertriglyceridemia in noninsulin dependent diabetes mellitus.
    Schonfeld G
    Semin Thromb Hemost; 1988 Apr; 14(2):184-8. PubMed ID: 3061003
    [No Abstract]   [Full Text] [Related]  

  • 36. [Apolipoproteins A-1 and B of the blood plasma and apolipoproteins A-1 of 2 high-density lipoprotein subclasses in ischemic heart disease patients with various lipoprotein spectra].
    Metel'skaia VA; Perova NV; Chernysheva NP; Kurdanov KhA; Polesskiĭ VA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(1):83-9. PubMed ID: 6407489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute lipidemic effect of calcium heparin in normolipemic and hyperlipemic subjects.
    Ferlito S; Ricceri M; Ossino AM
    Int Angiol; 1989; 8(3):140-4. PubMed ID: 2592796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein B and insulin resistance are good markers of carotid atherosclerosis in patients with type 2 diabetes mellitus.
    Matsumoto K; Fujita N; Nakamura K; Senoo T; Tominaga T; Ueki Y
    Diabetes Res Clin Pract; 2008 Oct; 82(1):93-7. PubMed ID: 18684539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The genetics and molecular biology of apolipoprotein CII.
    Hayden MR; Vergani C; Humphries SE; Kirby L; Shukin R; McLeod R
    Adv Exp Med Biol; 1986; 201():241-51. PubMed ID: 3541518
    [No Abstract]   [Full Text] [Related]  

  • 40. [Study on apolipoprotein CIII serum levels in 269 healthy adults in Chengdu district].
    Fu MD; Liu BW; Fang DZ; Fan P; Zhang P
    Hua Xi Yi Ke Da Xue Xue Bao; 1988 Sep; 19(3):246-8. PubMed ID: 3075583
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.